| 10-May-2023 | D | The Board has recommended the following dividend for the financial year ended March 31, 2023, subject to the approval of the shareholders of the Company at the ensuing Annual General Meeting (AGM):
a) Final dividend of 10.00 (Rupees Ten Only) per equity share of the face value of 5 each
b) One-time Special dividend of 37.50 (Rupees Thirty-Seven and Paise Fifty Only) per equity
share of the face value of 5 each, on occasion of Companys 75th Anniversary The total dividend amounts to 47.50 (Rupees Forty-Seven and Paise Fifty Only) per equity share of the face value of 5 each. Accordingly, the dividend, if approved by the shareholders, will be paid on or after August 02, 2023. | 20-Jul-2023 | |
| 10-May-2023 | D | The Board has recommended the following dividend for the financial year ended March 31, 2023, subject to the approval of the shareholders of the Company at the ensuing Annual General Meeting (AGM):
a) Final dividend of 10.00 (Rupees Ten Only) per equity share of the face value of 5 each
b) One-time Special dividend of 37.50 (Rupees Thirty-Seven and Paise Fifty Only) per equity
share of the face value of 5 each, on occasion of Companys 75th Anniversary The total dividend amounts to 47.50 (Rupees Forty-Seven and Paise Fifty Only) per equity share of the face value of 5 each. Accordingly, the dividend, if approved by the shareholders, will be paid on or after August 02, 2023. | 20-Jul-2023 | |
| 19-May-2022 | D | The Board has recommended final dividend of Rs. 10 per equity share (of the face value of Rs. 5 each) for the financial year ended March 31, 2022, subject to the approval of the shareholders of the Company at the ensuing Annual General Meeting ('AGM'). Accordingly, the said final dividend, if approved by the shareholders, will be paid on or after August 2, 2022. | 20-Jul-2022 | |
| 17-Jun-2021 | D | Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 17, 2021, inter alia, have approved the following:
- Recommendation of final dividend of Rs. 10/- per Equity share of Rs. 5/- each for the year ended March 31, 2021, subject to approval of the shareholders of the Company. | 17-Aug-2021 | |
| 19-Jun-2020 | D | Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 19, 2020, inter alia, have approved :
- Recommendation of final dividend of Rs. 10/- per Equity share of Rs. 5/- each for the year ended March 31, 2020, subject to approval of the shareholders of the Company. | 29-Jul-2020 | |
| 23-May-2019 | D | Novartis India Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 23, 2019, inter alia, has recommended final dividend of Rs. 10/- per equity share of Rs. 5/- each for the year ended March 31, 2019. | 31-Jul-2019 | |
| 10-May-2018 | D | Recommendation of final dividend of Rs 10/- per equity share of Rs 5/- each for the year ended March 31, 2018 | 18-Jul-2018 | |
| 23-May-2017 | D | Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 23, 2017, inter alia, has recommended a dividend of Rs. 10 per share for the financial year ended March 31, 2017, subject to the approval of Shareholders at the ensuing Annual General Meeting. The Dividend, if approved by the Shareholders, will be paid within the prescribed statutory timelines. | 19-Jul-2017 | |
| 26-May-2016 | D | Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2016, inter alia, has considered and approved the following items:
1. Dividend recommendation of Rs. 10/- per equity share of Rs. 5/- each for the year ended March 31, 2016. | 21-Jul-2016 | |
| 27-May-2015 | D | Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2015, inter alia, has considered and approved the following:
1. Dividend recommendation of Rs. 10/- per equity share of Rs. 5/- each for the year ended March 31, 2015; | 14-Jul-2015 | |
| 22-May-2014 | D | Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 22, 2014, inter alia, has considered and approved the following:
1. Dividend recommendation of Rs. 10/- per equity share of Rs. 5/- each for the year ended March 31, 2014. | 16-Jul-2014 | |
| 14-May-2013 | D | Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2013, inter alia, has considered and approved the following:
- Dividend recommendation of Rs. 10/- per equity share of Rs. 5 each for the year ended March 31, 2013.
The dividend, if approved by the shareholders, shall be payable on or after July 30, 2013. | 16-Jul-2013 | |
| 24-May-2012 | D | Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 24, 2012, inter alia, considered the following items :
1. Dividend recommendation of Rs 10/- per equity share of Rs .5 each for the year ended March 31, 2012.
Dividend, if approved by the shareholders, shall be payable on or after July 30, 2012. | 18-Jul-2012 | |
| 24-May-2011 | D | Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 24, 2011, inter alia, has recommended dividend of Rs. 10/- per equity share of Rs. 5 each for the above mentioned period. | 18-Jul-2011 | |
| 07-May-2010 | D | Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 07, 2010, inter alia, has considered the following:
Dividend recommendation of 200% (Rs. 10/- per equity share of Rs. 5 each) for the year ended March 31, 2010. | 21-Jul-2010 | |
| 08-May-2009 | D | Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 08, 2009, inter alia, has recommended Dividend of 200% (Rs 10/- per equity share of Rs 5 each) for the year ended March 31, 2009. | 08-Jul-2009 | |
| 09-May-2008 | D | Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 09, 2008, inter alia, has recommended a dividend of 200% (Rs 10/- per equity share of Rs 5 each) for the year ended March 31, 2008. | 07-Jul-2008 | |
| 19-Mar-2007 | D | Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 17, 2007, has approved payment of an interim dividend of Rs 10/- per shares (face value Rs 5/- per share).
Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 11, 2007, inter alia, has consider the following:
"Interim Dividend of 200% (Rs 10 per equity share of Rs 5 each) will be the final dividend."
(As Per BSE Announcement Website Dated on 11/05/2007) | 22-Mar-2007 | |
| 18-Jul-2005 | D | 200% Dividend | 20-Jul-2005 | |
| 27-Mar-2024 | BC | NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 inter alia to consider and approve the Audited Financial Results of the Compan | 10-May-2024 | |
| 01-Apr-2024 | BC | Resignation of Company Secretary / Compliance Officer | 30-Apr-2024 | |
| 25-Jan-2024 | BC | Outcome of the Meeting of the Board of Directors of Novartis India Limited held today i.e. Thursday, January 25, 2024
Resignation of Managing Director
| 02-Apr-2024 | |
| 17-Feb-2024 | BC | Appointment of Ms. Gira Sardesai (DIN: 02610502) as an Additional Director (Designated as Non-Executive and Independent Director)
Cessation by virtue of completion of tenure of Mr. Jai Hiremath (D | 31-Mar-2024 | |
| 20-Feb-2024 | BC | Notice of Postal Ballot
Intimation of Newspaper advertisement regarding completion of emailing of Notice of Postal Ballot to the Members
(As Per BSE Announcement Dated on 21.02.2024)
Declara | 21-Mar-2024 | |